Yatharth Hospital secures ₹3,150 crore Advent investment for 24.9% stake
- Advent International agrees to invest ₹3,150 crore in Yatharth Hospital
- The deal grants Advent a 24.9% stake via equity shares and warrants
- Tyagi family remains the largest shareholder post-investment
- Upfront payment covers full equity value plus 25% of warrant value
*this image is generated using AI for illustrative purposes only.
Yatharth Hospital has entered into a definitive agreement with global private equity firm Advent International to secure a ₹3,150.00 crore primary investment. The transaction values the hospital chain significantly as Advent acquires a 24.9% minority stake, subject to customary closing conditions.
The board meeting held on September 17, 2026 approved this preferential issue of equity shares and warrants. This infusion marks one of the largest primary capital injections by a private equity firm in India's hospital sector. The promoter, the Tyagi Family, will remain the largest shareholder.
Transaction Structure
The investment comprises two components issued on a private placement basis:
- Equity Shares: Up to 1,30,26,516 fully paid-up equity shares at ₹985.17 per share, aggregating ₹1,283.33 crore.
- Warrants: Up to 1,89,47,664 warrants at ₹985.17 each. Twenty-five percent (₹246.29) is payable upfront, with the balance 75% (₹738.88) due upon exercise.
| Component | Quantity | Price Per Unit | Aggregate Value |
|---|---|---|---|
| Equity Shares | 1,30,26,516 | ₹985.17 | ₹1,283.33 crore |
| Warrants | 1,89,47,664 | ₹985.17 | ₹1,866.67 crore |
Rasmalai Limited, the Cyprus-based entity through which Advent invests, will hold the stake on a fully diluted basis. Upon completion, the investor will be classified as a public shareholder.
Strategic Context
Founded in 2008, Yatharth Hospital operates nine multi-speciality hospitals with approximately 2,800 beds and an announced capacity of ~3,250 beds across North India. The company has expanded through organic growth and strategic acquisitions in the National Capital Region, Madhya Pradesh, and Haryana.
Mr. Yatharth Tyagi, Whole-time Director, stated that the investment validates the platform's strength and long-term vision. He noted that Advent brings deep healthcare expertise and global insights to accelerate the next phase of growth.
Pankaj Patwari, Managing Director at Advent, highlighted the structural growth potential in India's healthcare sector. He emphasized the partnership with the founder-led business to support scalable operations and clinical excellence.
What the Numbers Show
The warrant structure defers significant capital inflow. While the upfront cash consideration includes the full equity value plus only 25% of the warrant value, the remaining 75% of the warrant consideration is contingent on future exercise. This aligns immediate liquidity with long-term equity conversion potential for the hospital chain.
Historical Stock Returns for Yatharth Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.76% | +4.97% | +22.99% | +59.92% | +32.35% | +211.19% |
How will the deferred 75% warrant exercise price impact Yatharth Hospital's future cash flow and dilution risks if market conditions favor warrant conversion?
What specific operational metrics or expansion targets has Advent International set for Yatharth Hospital to justify this valuation within the next 3-5 years?
Will Advent International seek board representation or specific governance rights despite holding a minority stake, and how might this influence the Tyagi Family's strategic control?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
